LinkedIn / Adravision · Jul 2026
Recent company post describing Adravision as an infrastructure layer connecting practices, payers, and patients through shared intelligence.
Automation for dental clinics and insurance companies.
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Adravision is a dental AI infrastructure company that turns radiographs, records, and workflow data into structured outputs for diagnosis support, charting/documentation, claim review, and patient communication across dental practices, payers, and partners.
Primary product
AI-powered dental diagnostic and workflow platform (Adravision / Adravision 5handed)
Founded
2021
Headquarters
Atlanta, Georgia, United States
Team size
1-10
Industry
Hospitals and Health Care
Sub-industry
Dental AI / dental diagnostic software
Offices
0 jobs at Adravision
Check back later for new openings
Business model
Stage
Seed
Total raised
$1.4M
Latest round
Non-equity Assistance · Feb 2024
Latest amount
$100K
Feb 2024 · Bronze Valley
Aug 2021 · Y Combinator
Leadership
CEO, Co-Founder
CPO, Co-Founder
CTO, Co-Founder
Mission-driven, founder-led team of dentists, scientists, and technologists focused on improving oral health and education. The company emphasizes workflow efficiency, clinician support, and patient understanding, with a strong product and regulatory orientation.
Compensation
No public salary bands found. Third-party employer-review snippets show a positive compensation rating, but no specific pay ranges were published.
Pricing
No public list pricing disclosed; sold via demo-led enterprise SaaS, white-label, and embedded/API partnership models.
Differentiators
Technology
Customers
Competitors
Estimated revenue
≈$1.5M ARR (GetLatka estimate, 2025-04-10)
Estimated monthly visits
86
Traffic estimate as of Oct 2024
LinkedIn / Adravision · Jul 2026
Recent company post describing Adravision as an infrastructure layer connecting practices, payers, and patients through shared intelligence.
Adravision · Jan 2026
Company blog post arguing that clinically informed AI can improve claim review accuracy, reduce administrative burden, and speed adjudication for payers, providers, and patients.
LinkedIn / Adravision · May 2025
Adravision said it received TGA approval for its AI-powered dental software, enabling commercial distribution in Australia.
Adravision · Feb 2025
The company said its Adravision 5handed SaMD received Health Singapore Authority clearance in April 2024 for assessing 2D dental radiographs in permanent teeth.
Adravision · Oct 2024
Official announcement that Adravision partnered with Fluent to integrate Adravision AI into Fluent's oral-health optimization and utilization-review platform.